As injectable peptides surge online, researchers warn regulation is falling behind

As injectable peptides surge online, researchers warn regulation is falling behind

A new Viewpoint published in JAMA from researchers at the University of Queensland, the University of Toronto and the University of California, San Francisco, is raising concern about a fast-growing but poorly understood trend: the use of injectable peptides marketed online for enhancement purposes, often beyond the reach of traditional drug regulation.